Table: Kubota Pharmaceutical Holdings -6-MTH group results (IFRS)

Kubota Pharmaceutical Holdings

10/08/2023 07:01

Aug 10 (Reuters)- 
              Kubota Pharmaceutical Holdings Co., Ltd. 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   6 months ended      6 months ended       Year to 
                  Jun 30, 2023        Jun 30, 2022     Dec 31, 2023 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              17 mln                                         
  Operating       loss 747 mln          loss 1.17                   
  Pretax          loss 745 mln          loss 1.20                   
  Net             loss 745 mln          loss 1.20                   
  EPS Basic      loss 13.48 yen      loss 26.02 yen                 
  EPS Diluted    loss 13.48 yen      loss 26.02 yen                 
  Ann Div                                  NIL              NIL     
  -Q2 Div              NIL                 NIL                      
  -Q4 Div                                  NIL              NIL     
 
  NOTE - Kubota Pharmaceutical Holdings Co., Ltd.. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4596.T